AGN : Analysis & Opinions

  1. 3 ETFs Affected by the Failed Pfizer-Allergan Merger (PFE, AGN)

    May 28, 2016
    Discover three ETFs that were affected by the failed Pfizer and Allergan acquisition, and learn about the performances and ...
  2. CF Industries Drops Planned Purchase of OCI

    May 24, 2016
    A federal crackdown on tax inversion mergers has effectively killed a planned acquisition by fertilizer maker CF Industries' ...
  3. Allergan Stock Falls to New Low Ahead of Earnings (AGN, PFE)

    May 9, 2016
    Wall Street expects the maker of cosmetic injection Botox to deliver year-over-year declines in both revenue and profits.
  4. Pfizer Stock Rises Ahead of Earnings (PFE, AGN)

    May 2, 2016
    It turns out Pfizer might not have needed Allergan after all, given that PFE shares have surged 9% and 7.3% in the respective ...
  5. 6 Reasons to Watch Kythera Biopharm Inc. (AGN, PFE)

    May 1, 2016
    Discover why the Russell 2000 and other investment indexes believe California-based Kythera Biopharmaceuticals Inc. is a ...
  6. The 3 Largest Health Care ETFs (XLV, IBB)

    April 25, 2016
    Find out which exchange-traded funds (ETFs) are the largest in terms of total assets under management (AUM) in the health ...
  7. (VRX) Who are Valeant's Main Competitors?

    April 23, 2016
    Learn which companies Valeant is likely watching closely, since it is known for acquiring companies for their products rather ...
  8. Singer Gets Better End of AGN-PFE Deal Implosion

    April 12, 2016
    Paul Singer increased his stake in Allergen by 204.75% in the fourth quarter. How will this impact his portfolio since the ...
  9. Pfizer CEO: Let Us Invest in the U.S. (AGN, PFE)

    April 7, 2016
    Ian Read, Chairman and CEO of Pfizer, published an op-ed in the Wall Street Journal Wednesday, in which he defended the logical ...
  10. FPURX: Fidelity Puritan Fund's Portfolio Trends in 2016

    April 6, 2016
    Evaluate the composition of the Fidelity Puritan Fund, and consider how the fund's makeup has evolved between March 2015 ...
  11. Allergan's Fall Hits Hedge Funds Hard (AGN, PFE)

    April 6, 2016
    When shares in Allergan dropped 14.8% to $236.55 on Tuesday, not everyone realized how much – and how many – hedge funds ...
  12. FAGIX: Fidelity Capital & Income Fund's Top 5 Holdings Analysis

    April 6, 2016
    Evaluate the top five holdings of the Fidelity Capital & Income Fund, and study the basics and recent performance of the ...
  13. Pfizer Withdraws Merger Bid With Allergan (AGN, PFE)

    April 6, 2016
    Pfizer has come to realize the U.S. Treasury Department's new stance with inversions: "Over my dead body."
  14. FSPHX: Fidelity Select Healthcare Fund's Top 5 Holdings Analysis

    April 6, 2016
    Learn about the top five holdings in the four-star rated Fidelity Select Health Care fund, managed by top portfolio manager, ...
  15. FPHAX: Fidelity Select Pharma Fund Portfolio Trends in 2016

    April 5, 2016
    Evaluate the composition of the Fidelity Select Pharmaceuticals Portfolio, and learn how the fund's makeup has evolved between ...
  16. Allergan Now Trades Cheaper Than Its Standalone Value

    April 5, 2016
    Shibani Malhotra of Nomura thinks Allergan plc Ordinary Shares (NYSE: AGN) is compelling, despite treasury notice that threatens ...
  17. The Market In 5 Minutes: Tuesday, April 5, 2016

    April 5, 2016
    Below is a tool used by the Benzinga News Desk each trading day -- it's a look at everything happening in the market, in ...
  18. Allergan Crushed as Tax Inversion Rules Threaten PFE Deal (AGN, ...

    April 5, 2016
    Given the army of lawyers, not to mention lobbyists, on their respective payrolls, Allergen and Pfizer are not likely to ...
  19. FPHAX: Fidelity Select Pharma Fund Top 5 Holdings Analysis

    April 2, 2016
    Explore the five largest holdings of the Fidelity Pharmaceuticals Select Portfolio. Learn about the top products and drug ...
  20. VGHCX: Vanguard Healthcare Fund Top 5 Holdings Analysis

    April 2, 2016
    Find out which of the five largest health care companies hold the top five positions in the $46 billion Vanguard Health Care ...
  21. PRHSX: T. Rowe Health Sciences Fund Top 5 Holdings Analysis

    April 2, 2016
    Learn about the T. Rowe Price Health Sciences mutual fund, its portfolio make-up, and complete analysis of the fund's top ...
  22. VGHCX: Portfolio Trends in 2016

    March 25, 2016
    Evaluate the composition of the Vanguard Health Care Fund, and study how the fund's makeup has evolved over the previous ...
  23. PRHSX: Portfolio Trends in 2016

    March 23, 2016
    Discover how the T. Rowe Price Health Sciences Fund is positioned in 2016, and learn what trends in the portfolio may help ...
  24. FPHAX: Overview of Fidelity Select Pharmaceuticals Fund

    March 20, 2016
    Learn about the pharmaceutical industry, including the two main threats it faces in 2016 and an analysis of the Fidelity ...
  25. TROW: Overview of T. Rowe Price Health Sciences Fund

    March 20, 2016
    Learn about the health care sector's performance in 2016 and how T. Rowe Price's funds have fared. Discover an overview of ...
  26. VGHCX: Overview of Vanguard Health Care Fund

    March 19, 2016
    Find out about the Vanguard Health Care Fund in this fund overview, with information on investment performance and fund management.
  27. (XLV) Healthcare SPDR ETF: Top 5 Holdings

    March 18, 2016
    Discover the top five stocks in the Health Care Select Sector SPDR Fund, and learn if they can help power your portfolio ...
  28. The 5 Highest Paid Executives in the Healthcare Sector (AGN, ...

    March 18, 2016
    Discover who the highest paid executives in the health care sector are and how much they make, while the cost of health care ...
  29. Analyzing Actavis' Price & Profitability Ratios in 2016 (AGN)

    March 5, 2016
    Analyze several price ratios and profitability ratios to evaluate the specialty pharmaceutical company, Allergan PLC.
  30. Top 5 Positions in Janus Capital Management's Portfolio (JNS, ...

    February 29, 2016
    Explore detailed analyses of the top five positions in Janus Capital Management's portfolio based on the company's September ...
  31. Top 5 Positions in John Paulson's Portfolio (AGN, VRX)

    February 29, 2016
    Find out which stocks are holding the top five positions in investment guru John Paulson's hedge fund portfolio and which ...
  32. The Top 5 Positions in Barry Rosenstein's Portfolio (QCOM, HTZ)

    February 27, 2016
    Take a look at the top five holdings for billionaire investor Barry Rosenstein, founder of activist investment advisory fund ...
  33. Mind the GAAP: Buyer, Beware Profit 'Adjustment'

    February 25, 2016
    S&P 500 companies are reporting "adjusted" earnings that are much more enticing than their profits according to generally ...
  34. Allergan: An Activist Investment Analysis (AGN,VRX)

    January 28, 2016
    Read about the activist investor campaign against Allergan by Bill Ackman. See how Ackman partnered with another drug company ...
  35. How the New Allergan Plc Will Make Money

    January 14, 2016
    Allergan plc is not only enormous, it's about to more than double in size. Here's why and how.
  36. The Top 10 Healthcare Stocks for 2016 (ABT, AGN)

    January 6, 2016
    Learn about the top 10 health care stocks expected to grow in 2016, with brief insights into each company's growth potential ...
  37. 5 Big M&A deals in 2015 (PFE, AGN)

    December 23, 2015
    Learn how these mergers and acquisitions helped make 2015 a boom year for M&A deals, with the total value of the companies ...
  38. 3 Popular Healthcare Stocks in 2015 (CVS, AGN)

    December 23, 2015
    Discover the three most popular health care stocks of 2015, including an affordable stock that caught BlackRock Investment ...
  39. M&A Hits a Record in 2015

    December 4, 2015
    2015 has been a record year for mergers and acquisitions as M&A activity hit record levels, fuelled by consolidation in various ...
  40. Retail Investors May Face Capital Gains Tax on Pfizer Allergan ...

    November 30, 2015
    The Pfizer-Allergan merger may end up costing retail investors a pretty penny, but they may be able to minimize their losses. ...
  41. Why Are Pfizer And Allergan Talking About A Split Even Before ...

    November 24, 2015
    The proposed merger between Pfizer and Allergan might be headed towards a split in the future. Why?
  42. Positive GDP Number Increases Chance of Rate Hike

    November 24, 2015
    The chances for a December hike in interest rates became stronger this morning with an uptick in U.S. GDP numbers during ...
  43. Pfizer-Allergan Merger Makes Biggest Firm by Sales

    November 23, 2015
    On November 22, 2015, America’s Pfizer and Ireland’s Allergan received their board of directors’ approval to merge in what ...
  44. New Treasury Rules Won't Stop Corporate Inversions (PFE, AGN)

    November 20, 2015
    The US Treasury Department unveiled new rules to curb corporate inversions. But, they may not be enough.
  45. Pfizer and Allergan Talk Mammoth Healthcare Deal

    November 19, 2015
    Pharmaceutical giant Pfizer Inc. is in talks with Botox maker Allergan Plc, to buy the latter in a deal worth $150 billion.
  46. Defensive Investing: Learn from a Hedge Fund Pro

    November 12, 2015
    Looking for ideas on companies, sectors or investments to short? Consider the opinion of this hedge fund luminary.
  47. Pfizer - Allergan: Will This Deal Happen? (PFE, AGN)

    October 30, 2015
    The question for investors is: Will this deal happen?
  48. Target Fires First Shot in Holiday Wars at Wal-Mart

    October 30, 2015
    In a move that has threatened retail giant WalMart (WMT), Target (TGT) has announced that it will offer free shipping and ...
  49. Teva Pharma to Acquire Allergan: Analysts Weigh In

    July 28, 2015
    Teva Pharmaceutical announced a definitive agreement to buy Allergan Inc. for $40.5 billion. What analysts are saying?
  50. Will These High-Flying Stocks Stay Hot in 2015?

    May 22, 2015
    These 10 stocks were on fire in 2014. Will they stay hot?
  51. The Best Way Into Big Pharma? See This ETF (IHE)

    November 21, 2014
    Pharma investing isn't for everyone, but sector-specific ETFs, such as the iShares Dow Jones U.S. Pharmaceuticals ETF (IHE), ...
  52. All Quiet On The Market Front: Dow, S&P 500, Nasdaq Virtually ...

    November 12, 2014
  53. Technical Outlook For Four Exceptionally Hot Stocks

    January 15, 2014
    These four large cap stocks are all up more than 30% in the last three months. Here's the technical outlook going forward.
  54. Yet Another Failure Has Rigel Pharmaceuticals Almost Back To ...

    August 26, 2013
    Rigel sees yet another clinical failure from its pipeline.
  55. After A Sharp Pullback, Is Allergan Pretty Enough?

    July 31, 2013
    Down on fears about generics and the pipeline, the Street may be underestimating Allergan
  56. Valeant Eyes Bausch & Lomb

    May 28, 2013
    Canadian pharmaceutical company Valeant has made a name for itself through acquisitions. On May 27 it announced that it was ...
  57. Allergan Third Quarter Earnings

    October 30, 2012
    Allergan (NYSE:AGN) announced its results for the most recent quarter on October 30, 2012. Allergan is a global specialty ...
  58. Valeant Works Its Mojo With Medicis

    September 7, 2012
    Valeant makes a bold but logical bid for Medicis.
  59. Allergan and Other NYSE Stocks Making Big Moves

    August 1, 2012
    After this morning's trading, the market is looking good. The Nasdaq has increased 0.1%; the S&P 500 is trading up 0.5%; ...
  60. Obagi Puts Its Problems Behind It

    May 25, 2012
    A year ago, Obagi Medical Products faced some problems in Texas that presented an investment opportunity. One year later ...
  61. 6 Overbought Stocks To Watch

    March 30, 2012
    Let's take a look at a few stocks that have recently entered overbought territory because these could be candidates for a ...
  62. Top Drug Stocks

    June 30, 2011
    Recently, three strong factors are driving investors to the drug sector.
  63. Obagi's Pitfalls Provide Investment Opportunity

    May 24, 2011
    Obagi's stock dropped 24% after announcing a 13-cent loss in its first quarter. Find out why this presents an opportunity ...
  64. Novartis Brings Alcon Into The Fold

    December 16, 2010
    Novartis closes the deal for Alcon.
  65. Allergan Winning Wall Street's Beauty Pageant

    November 3, 2010
    Allergan's earnings aren't special, but the stock is basking in Wall Street's love. Is it simply a case of lipstick on a ...
  66. Novartis Looks For 20/20 Vision With Alcon

    January 11, 2010
    The Swiss drug maker hopes to take full ownership of Alcon later in the year. Find out what it'll mean for these two companies.
Trading Center